Custom-Made vaccine takes on deadly skin cancer
NCT ID NCT00626860
First seen Jan 23, 2026 · Last updated Jun 07, 2026 · Updated 18 times
Summary
This study tested a new type of vaccine made by fusing a patient's own cancer cells with their immune cells (dendritic cells). The goal was to see if this personalized vaccine is safe and can trigger the immune system to attack advanced melanoma. Twenty adults with progressive, measurable metastatic melanoma participated. The approach aims to train the body to fight the cancer without using lifelong medication.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC MELANOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
BIDMC
Boston, Massachusetts, 02215, United States
Conditions
Explore the condition pages connected to this study.